Skip to main content

Medical Applications of Affinity Chromatography

  • Chapter

Abstract

Metabolic waste products are cleared from the body primarily by the kidney and liver. Low molecular weight, non protein-bound molecules such as urea, creatinine and uric acid are filtered at the glomerulus and excreted in the urine. When the kidneys fail, hemodialysis is an effective means of removing these substances from the blood, and the widespread use of hemodialysis has significantly prolonged the useful life of many patients with renal disease. Protein-bound metabolic waste products such as bilirubin (BR), as well as many exogenously administered drugs, circulate in plasma tightly bound to serum albumin, are non-dialyzable, and are not excreted in the urine. Instead, these substances are cleared almost exclusively by the liver and are excreted in the bile. At present, there exists no generally effective technique for removing these substances from the blood of patients with liver failure.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. WILCHEK, M. Anal. Biochem. 49: 572, 1972.

    Article  Google Scholar 

  2. PLOTZ, P.H., BERK, P.D., SCHARSCHMIDT, B.F., GORDON, J.K. & VERGALLA, J. J. Clin. Invest. 53: 778, 1974.

    Article  Google Scholar 

  3. AXÉN, R., PORATH, J. & ERNBACK, S. Nature, 214: 1302, 1967.

    Article  Google Scholar 

  4. CUATRECASAS, P., WILCHEK, M. & ANFINSEN, C.B. Proc. Natl. Acad. Sci. U.S.A. 61: 636, 1968.

    Article  Google Scholar 

  5. SCHARSCHMIDT, B.F., PLOTZ, P.H., BERK, P.D., WAGGONER, J.G. & VERGALLA, J. J. Clin. Invest. 53: 786, 1974.

    Article  Google Scholar 

  6. SCHARSCHMIDT, B.F., MARTIN, J.F., SHAPIRO, L.J., PLOTZ, P.H., BERK, P.D., GORDON, J.K., WAGGONER, J.G. & VERGALLA, J. Clin. Res. 23: 256A, 1975.

    Google Scholar 

  7. SCHARSCHMIDT, B.F., MARTIN, J.F., SHAPIRO, L.J., PLOTZ, P.H. & BERK. P.D. Gastroenterology 69: 864, 1975.

    Google Scholar 

  8. SCHARSCHMIDT, B.F., MARTIN, J.F., SHAPIRO, L.J., PLOTZ, P.H. & BERK, P.D. Gastroenterology 69: 864, 1975.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1978 Springer Science+Business Media New York

About this chapter

Cite this chapter

Scharschmidt, B.F., Martin, J.F., Plotz, P.H., Shapiro, L.J., Berk, P.D. (1978). Medical Applications of Affinity Chromatography. In: Pye, E.K., Weetall, H.H. (eds) Enzyme Engineering. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5163-5_47

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5163-5_47

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-5165-9

  • Online ISBN: 978-1-4757-5163-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics